Patología Vascular y Trombosis
VYTRO
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clínico Universitario Lozano Blesa (32)
2024
-
Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología
Neurologia
-
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Frontiers in Neurology , Vol. 15
2023
-
Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, pp. S37-S52
-
Recomendaciones de consenso para el tratamiento de la prevención de la migraña
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
-
[Translated article] Consensus recommendations on the preventive treatment of migraine
Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T246-T253
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
-
Cutaneous Allodynia in Migraine: A Narrative Review
Frontiers in Neurology, Vol. 12
-
SEA 2022 Standards for Global Control of Cardiovascular Risk
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179
-
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain
Neurologia
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 2, pp. 285-297
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Leukemia, Vol. 35, Núm. 1, pp. 245-249
-
Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas
Scientific Reports, Vol. 11, Núm. 1
-
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Journal of Headache and Pain, Vol. 22, Núm. 1
-
Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery
Neurologia, Vol. 36, Núm. 1, pp. 61-79
-
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Neurologia, Vol. 36, Núm. 8, pp. 611-617
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2020
-
Estimating the savings associated with a migraine-free life: results from the Spanish Atlas
European Journal of Neurology, Vol. 27, Núm. 12, pp. 2616-2624